Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Bimi International Medical Inc

BIMI
Current price
1.09 USD -0.02 USD (-1.80%)
Last closed 1.07 USD
Sector Healthcare
Industry Pharmaceutical Retailers
Exchange NASDAQ
Capitalization 14 985 252 USD
Yield for 12 month +23.86 %
1Y
3Y
5Y
10Y
15Y
BIMI
21.11.2021 - 28.11.2021

BIMI Holdings Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. It distributes Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to drug stores, private clinics, pharmaceutical dealers, and hospitals in the Southwest region of the People's Republic of China. The company also distributes varieties of products, including raw ingredients for pharmaceutical products, antibiotics, cardiovascular drugs, and anti-obesity medicines. In addition, it offers prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines, personal and family care products, medical devices, and miscellaneous items under the Lijiantang Pharmacy brand name. Further, the company provides medical services in the hospitals, as well as IT research and development services; and operates two private hospitals in China. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as BIMI International Medical Inc. and changed its name to BIMI Holdings Inc. in January 2024. BIMI Holdings Inc. was incorporated in 2000 and is headquartered in New York, New York. Address: 725 5th Avenue, New York, NY, United States, 10022

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

12.5 USD

P/E ratio

Dividend Yield

Current Year

+12 632 651 USD

Last Year

+11 830 379 USD

Current Quarter

+2 532 193 USD

Last Quarter

+5 557 666 USD

Current Year

+5 091 340 USD

Last Year

+1 949 950 USD

Current Quarter

+115 155 USD

Last Quarter

+2 884 080 USD

Key Figures BIMI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -6 834 367 USD
Operating Margin TTM -124.83 %
PE Ratio
Return On Assets TTM -13.01 %
PEG Ratio
Return On Equity TTM -103.78 %
Wall Street Target Price 12.5 USD
Revenue TTM 12 632 651 USD
Book Value 1.31 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -48.8 %
Dividend Yield
Gross Profit TTM 4 596 391 USD
Earnings per share -6.39 USD
Diluted Eps TTM -6.39 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin -83.2 %

Dividend Analytics BIMI

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History BIMI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:10
Payout Ratio
Last Split Date 12.12.2022
Dividend Date

Stock Valuation BIMI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.428
Price Sales TTM 1.1529
Enterprise Value EBITDA -1.9565
Price Book MRQ 1.6727

Financials BIMI

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BIMI

For 52 weeks

0.88 USD 4.13 USD
50 Day MA 1.42 USD
Shares Short Prior Month 27 335
200 Day MA 2 USD
Short Ratio 0.4
Shares Short 10 954
Short Percent 0.46 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

430.32 USD Microsoft Corporation +0.69 (+0.16%)
Detailed analytics

ETF funds


S

SX7EEX

14.75 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) 0 (0%)
Detailed analytics

Metals


Gold

2357.98 USD Gold +6.23 (+0.27%)
Detailed analytics